Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.97
  • Today's Change0.002 / 0.21%
  • Shares traded808.60k
  • 1 Year change+13.05%
  • Beta0.2438
Data delayed at least 20 minutes, as of Feb 18 2026 16:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BioPharma Credit PLC is a United Kingdom-based closed-ended investment company. The Company is a specialist debt investor in the life sciences industry. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. It seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products. The Company may also invest in equity issued by a life sciences company, acquired directly from the life sciences company or in the secondary market. It will seek to create a diversified portfolio of investments by investing across a range of different forms of debt assets issued by a variety of borrowers. It has two wholly owned subsidiaries: BPCR Limited Partnership and BPCR GP Limited. The Company holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership.

  • Revenue in USD (TTM)154.69m
  • Net income in USD123.12m
  • Incorporated2016
  • Employees13.00
  • Location
    BioPharma Credit PLC51 New North RoadEXETER EX4 4EPUnited KingdomGBR
  • Phone+44 139 247 7503
  • Websitehttps://bpcruk.com/#
More ▼

Profile

Management group(s)Pharmakon Advisors L.P.
AIC sectorDebt - Direct Lending
ISINGB00BDGKMY29
Launch date27 Mar 2017
Share typeOrdinary Share
StructureInvestment Trust
Base currencyUSD

Objective

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets, which include Royalty Investments, Senior Secured Debt, Unsecured Debt and Credit Linked Notes.

Managed by

Pedro Gonzalez de Cosio, Pablo Legorreta, Martin Friedman

Management & contract fees

Annual management fee is 1% of NAV. The performance fee is calculated as 10% of returns, subject to High Watermark and a 6% preferred return hurdle with 50% catch up.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Baillie Gifford Japan Trust PLC179.65m167.49m955.14m0.006.000.9223--5.321.561.561.6210.170.1469--49.55--13.703.1615.463.3594.9482.9193.2376.61----0.128326.6583.5118.6893.5921.33--17.32
Pacific Horizon Investment Trust PLC65.25m59.10m1.04bn0.0018.941.29--15.960.48880.48880.53837.160.0759--60.41--6.874.517.104.6689.5887.9090.5776.84----0.05516.6313.64-10.4161.82-11.60--43.10
European Smaller Companies Trust PLC139.40m122.20m1.05bn0.008.190.9891--7.570.27120.27120.2742.240.1451--15.94--12.7210.9513.7612.2190.9289.2487.6686.43----0.015818.245.3540.766.0846.11--12.25
Baillie Gifford US Growth Trust PLC87.98m76.83m1.06bn0.0015.210.9365--12.060.18570.18570.22413.020.0754--65.93--6.595.346.915.5693.0090.4887.3285.15--26.140.00--48.180.28950.60-0.4121----
Capital Gearing Trust plc60.89m54.54m1.08bn0.0022.521.00--17.702.222.222.4149.880.0493--3.88--4.412.754.472.7891.7088.0789.5781.32----0.0052.6885.89--162.04----32.47
Cordiant Digital Infrastructure Ltd230.18m207.98m1.09bn0.005.220.7462--4.720.20020.20020.22151.400.1446--17.46--13.06--15.14--96.22--90.36----21.770.1321--14.69--31.07------
Biopharma Credit PLC154.69m123.12m1.09bn13.009.190.9503--7.070.10530.10530.13171.020.1295--3.4011,899,000.0010.318.6410.358.7480.9683.3979.5981.79----0.00106.8010.53-0.114912.66-0.0245--0.00
Edinburgh Worldwide Investment Trust plc256.20m240.18m1.10bn0.004.661.06--4.290.50200.50200.52112.210.2391--158.00--22.41-6.6225.22-7.3295.53--93.75------0.0922--127.89-10.49146.93-11.28----
Global Smaller Companies Trust PLC80.22m69.68m1.10bn0.0015.751.02--13.700.12150.12150.13131.880.0652--1.97--5.666.505.956.6390.7191.6786.8688.83----0.058719.55-145.59---163.00----12.03
Impax Environmental Markets plc-43.25m-62.68m1.12bn0.00--1.04-----0.2057-0.2057-0.13484.14-0.0296-------4.294.58-4.394.64--83.69--79.92----0.091918.06-106.05---142.57----10.76
Molten Ventures PLC186.04m150.89m1.14bn62.007.700.70447.526.120.6240.6240.76756.820.0983--39.742,211,290.007.974.528.024.56----81.1167.71--11.620.0860.00191.21-3.4798.03--1.68--
Scottish American Investment Company PLC28.33m13.35m1.16bn0.0092.290.9743--40.860.05670.05670.11925.370.02--5.25--0.94397.110.94717.2665.9589.7047.1185.64----0.093834.97-45.50-11.92-50.62-13.57--4.61
Finsbury Growth & Income Trust PLC-4.40m-18.84m1.17bn0.00--0.821345.19---0.0975-0.0975-0.02199.23-0.0023-------0.96533.34-0.97813.36--84.40--82.14----0.023259.71-102.68---112.84----4.00
Schroder Oriental Income Fund Ltd148.59m128.23m1.17bn0.009.361.20--7.890.40860.40860.46973.190.1436--21.48--12.398.9813.199.5689.2488.0786.3084.07----0.048142.67-12.73128.60-14.40----3.44
Murray Income Trust plc40.96m31.05m1.21bn0.0039.181.01--29.620.24070.24070.29859.360.0282--2.45--2.135.782.165.8480.5391.5975.7989.09----0.10964.01-70.59---75.86----3.15
Oakley Capital Investments Ltd100.28m75.17m1.22bn0.0016.610.7279--12.170.32510.32510.42447.420.0521--19.64--3.9012.524.3912.72111.37--74.9693.69--7.470.12215.71-26.65-22.84-43.45-27.63--0.00
Data as of Feb 18 2026. Currency figures normalised to BioPharma Credit PLC's reporting currency: US Dollar USD

Institutional shareholders

35.24%Per cent of shares held by top holders
HolderShares% Held
Newton Investment Management Ltd.as of 31 Dec 2024136.38m12.08%
Sarasin & Partners LLPas of 31 Dec 202470.48m6.24%
M&G Investment Management Ltd.as of 31 Dec 202467.22m5.95%
JPMorgan Chase Bank, NA (Investment Management)as of 01 Jan 202623.75m2.10%
City of London Investment Management Co. Ltd.as of 01 Jan 202621.34m1.89%
Morgan Stanley Smith Barney LLC (Investment Management)as of 01 Jan 202616.79m1.49%
Abrdn Asia Ltd.as of 30 Jan 202616.54m1.47%
abrdn, Inc.as of 30 Jan 202616.16m1.43%
West Yorkshire Pension Fundas of 01 Jan 202615.00m1.33%
abrdn Investments Ltd.as of 01 Jan 202614.30m1.27%
More ▼
Data from 31 Mar 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.